197 related articles for article (PubMed ID: 6145472)
1. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
Clare KA; Scrutton MC; Thompson NT
Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
3. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
4. Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets.
Grant JA; Scrutton MC
Br J Pharmacol; 1980; 71(1):121-34. PubMed ID: 6110451
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets.
Swart SS; Maguire M; Wood JK; Barnett DB
Eur J Pharmacol; 1985 Oct; 116(1-2):113-9. PubMed ID: 2996911
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
Farndale RW; Winkler AB; Martin BR; Barnes MJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
[TBL] [Abstract][Full Text] [Related]
7. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
Hall DA; Hourani SM
Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling of alpha-adrenoceptor-mediated inhibition of human platelet adenylate cyclase by N-ethylmaleimide.
Jakobs KH; Lasch P; Minuth M; Aktories K; Schultz G
J Biol Chem; 1982 Mar; 257(6):2829-33. PubMed ID: 6277915
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
10. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine.
Jakobs KH; Saur W; Schultz G
J Cyclic Nucleotide Res; 1976; 2(6):381-92. PubMed ID: 14175
[TBL] [Abstract][Full Text] [Related]
11. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
Macfarlane DE; Mills DC; Srivastava PC
Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
[No Abstract] [Full Text] [Related]
12. Alpha 2-adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment.
García-Sevilla JA; Padró D; Giralt MT; Guimón J; Areso P
Arch Gen Psychiatry; 1990 Feb; 47(2):125-32. PubMed ID: 1967926
[TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
Tremblay J; Hamet P
Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
Haslam RJ; Vanderwel M
J Biol Chem; 1982 Jun; 257(12):6879-85. PubMed ID: 6177688
[No Abstract] [Full Text] [Related]
15. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
16. Stereostructure activity relationships of catecholamines on human platelet function.
Ahn CH; Shams G; Schotzinger RL; Miller DD; Feller DR
Proc Soc Exp Biol Med; 1990 Jun; 194(2):149-56. PubMed ID: 2190233
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man.
Jones CR; Giembcyz M; Hamilton CA; Rodger IW; Whyte K; Deighton N; Elliott HL; Reid JL
Clin Sci (Lond); 1986 Feb; 70(2):147-53. PubMed ID: 2869850
[TBL] [Abstract][Full Text] [Related]
18. Effects of protein kinase C activation on human platelet cyclic AMP metabolism.
Bushfield M; Hopple SL; Gibson IF; Murdoch FA; MacIntyre DE
FEBS Lett; 1987 Oct; 222(2):299-304. PubMed ID: 2820806
[TBL] [Abstract][Full Text] [Related]
19. Platelet beta-adrenoceptors.
Kerry R; Scrutton MC
Br J Pharmacol; 1983 Jul; 79(3):681-91. PubMed ID: 6140045
[TBL] [Abstract][Full Text] [Related]
20. Determination of the turn-off reaction for the epinephrine-inhibited human platelet adenylate cyclase.
Jakobs KH
Eur J Biochem; 1983 Apr; 132(1):125-30. PubMed ID: 6301820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
